Physician
Cavallo, Allison
Cavallo, Allison was paid $494K by Medicaid between Sep 2018 and Nov 2024, across 77 billing codes. Its largest line is 85025, Blood count; complete (CBC), automated, and automated differential WBC count — 14% of everything it billed.
33Billing provider infoCAVALLO, ALLISON
LOCKPORT, IL 60441
LOCKPORT, IL 60441
33aNPI1528354842assigned 06/24/2011
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$494K
24GClaims134,316
24DCodes billed77
24AFirst – last monthSep 2018 – Nov 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Rank by total paid#83 of 398
Median peer was paid$66K
This provider vs. median7.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27 | $135.60 | |
| 2019 | 24 | $452.00 | |
| 2020 | 44 | $963.00 | |
| 2021 | 31,778 | $124K | |
| 2022 | 77,564 | $278K | |
| 2023 | 24,850 | $89K | |
| 2024incomplete | 29 | $645.95 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 14% | 24,340 | 15,358 | $68K |
| 80053 | Comprehensive metabolic panel | 13% | 13,223 | 9,627 | $67K |
| 83735 | 9.2% | 13,611 | 7,808 | $46K | |
| 84484 | 6.3% | 7,449 | 5,883 | $31K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.6% | 5,473 | 2,502 | $23K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.2% | 3,496 | 3,046 | $21K |
| 84703 | 4.0% | 5,642 | 4,995 | $20K | |
| 87040 | 3.3% | 1,622 | 1,331 | $16K | |
| 83690 | 2.9% | 4,143 | 3,460 | $14K | |
| 85055 | 2.7% | 2,295 | 1,173 | $13K | |
| 85027 | 2.3% | 4,105 | 2,530 | $12K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.2% | 1,898 | 1,802 | $11K |
65 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.2% | 1,848 | $11K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.7% | 1,602 | $8K |
| 87081 | 1.7% | 2,811 | $8K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.6% | 1,355 | $8K |
| 83880 | 1.3% | 1,150 | $7K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.2% | 308 | $6K |
| 86850 | 1.2% | 1,984 | $6K | |
| 85379 | 1.2% | 1,564 | $6K | |
| 86901 | 1.1% | 2,339 | $5K | |
| 85610 | 1.1% | 2,803 | $5K | |
| 84100 | <1% | 2,187 | $5K | |
| 81001 | <1% | 3,372 | $5K | |
| 87186 | <1% | 789 | $5K | |
| 86900 | <1% | 2,344 | $4K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 640 | $4K |
| 82607 | <1% | 622 | $4K | |
| 82746 | <1% | 589 | $3K | |
| 80069 | <1% | 807 | $3K | |
| 88307 | <1% | 43 | $3K | |
| 82140 | <1% | 692 | $3K | |
| 84702 | <1% | 638 | $3K | |
| 81003 | <1% | 2,653 | $3K | |
| 86140 | <1% | 1,203 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 902 | $3K |
| 85730 | <1% | 824 | $3K | |
| 87075 | <1% | 369 | $2K | |
| 87070 | <1% | 639 | $2K | |
| 82728 | <1% | 555 | $2K | |
| 82550 | <1% | 659 | $2K | |
| 82247 | <1% | 693 | $2K | |
| 81025 | <1% | 629 | $2K | |
| 83615 | <1% | 526 | $2K | |
| 83540 | <1% | 491 | $1K | |
| 87205 | <1% | 771 | $1K | |
| 82248 | <1% | 763 | $1K | |
| 84466 | <1% | 313 | $1K | |
| 82570 | <1% | 458 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 165 | $978.00 |
| 85652 | <1% | 700 | $906.73 | |
| 87147 | <1% | 488 | $798.83 | |
| 84439 | <1% | 182 | $789.83 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 131 | $777.90 |
| 84550 | <1% | 355 | $731.09 | |
| 84300 | <1% | 281 | $594.48 | |
| 80061 | Lipid panel | <1% | 156 | $593.37 |
| 85014 | <1% | 384 | $522.30 | |
| 85018 | <1% | 380 | $515.34 | |
| 80164 | <1% | 52 | $306.50 | |
| 88304 | <1% | 14 | $282.30 | |
| 82272 | <1% | 192 | $229.39 | |
| 84156 | <1% | 195 | $213.10 | |
| 86308 | <1% | 90 | $209.40 | |
| 85520 | <1% | 52 | $208.29 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 35 | $198.60 |
| 87340 | <1% | 28 | $168.00 | |
| 85060 | <1% | 12 | $152.76 | |
| 87641 | <1% | 26 | $152.40 | |
| 85384 | <1% | 33 | $96.35 | |
| 83935 | <1% | 37 | $83.88 | |
| 87045 | <1% | 12 | $66.00 | |
| 89051 | <1% | 18 | $65.10 | |
| 87046 | <1% | 12 | $42.45 | |
| 83930 | <1% | 14 | $32.62 | |
| 85045 | <1% | 27 | $27.51 | |
| 80050 | General health panel | <1% | 13 | $3.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.